ArticlePsycho-oncology2021

Evaluating the impact of the Patient Preference Assessment Tool on clinicians' recommendations for phase I oncology clinical trials.

Rachel S Hianik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.